Translating artificial intelligence from code to bedside: The road towards AI-driven predictive biomarkers for immunotherapy of hepatocellular carcinoma

J Hepatol. 2022 Jul;77(1):6-8. doi: 10.1016/j.jhep.2022.03.035. Epub 2022 Apr 10.

Author

Julius Chapiro¹

Affiliation

¹ Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT United States. Electronic address: julius.chapiro@yale.edu.

PMID: 35417743
DOI: 10.1016/j.jhep.2022.03.035

No abstract available

Publication types

Editorial
Comment

MeSH terms

Artificial Intelligence
Biomarkers
Carcinoma, Hepatocellular* / therapy
Humans
Immunotherapy
Liver Neoplasms* / therapy

Substances

Biomarkers